Skip to main content
PMC home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 2003 Jun;111(8):1007–1019. doi: 10.1289/ehp.6310

Environmental pollutants and breast cancer.

Julia Green Brody 1, Ruthann A Rudel 1
PMCID: PMC1241551  PMID: 12826474

Abstract

Breast cancer is the most common cancer in women and the leading cause of cancer death among women 35-54 years of age. Rising incidence, increased risk among migrants to higher risk regions, and poor prediction of individual risk have prompted a search for additional modifiable factors. Risk factors for breast cancer include reproductive characteristics associated with estrogen and other hormones, pharmaceutical hormones, and activities such as alcohol use and lack of exercise that affect hormone levels. As a result, investigation of hormonally active compounds in commercial products and pollution is a priority. Compounds that cause mammary tumors in animals are additional priorities. Animal models provide insight into possible mechanisms for effects of environmental pollutants on breast cancer and identify chemical exposures to target in epidemiologic studies. Although few epidemiologic studies have been conducted for chemical exposures, occupational studies show associations between breast cancer and exposure to certain organic solvents and polycyclic aromatic hydrocarbons (PAHs). Population-based studies have been limited to a few organochlorine compounds and PAHs and have been mostly negative. A variety of challenges in studies of breast cancer and the environment may have contributed to negative findings. Lack of exposure assessment tools and few hypothesis-generating toxicologic studies limit the scope of epidemiologic studies. Issues of timing with respect to latency and periods of breast vulnerability, and individual differences in susceptibility pose other challenges. Substantial work is needed in exposure assessment, toxicology, and susceptibility before we can expect a pay-off from large epidemiologic studies of breast cancer and environment.

Full Text

The Full Text of this article is available as a PDF (193.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams J. B. Enzymatic regulation of estradiol-17 beta concentrations in human breast cancer cells. Breast Cancer Res Treat. 1992 Mar;20(3):145–154. doi: 10.1007/BF01834620. [DOI] [PubMed] [Google Scholar]
  2. Adams J. B., Vrahimis R., Phillips N. Regulation of estrogen sulfotransferase by estrogen in MCF-7 human mammary cancer cells. Breast Cancer Res Treat. 1992;22(2):157–161. doi: 10.1007/BF01833346. [DOI] [PubMed] [Google Scholar]
  3. Adlercreutz C. H., Goldin B. R., Gorbach S. L., Höckerstedt K. A., Watanabe S., Hämäläinen E. K., Markkanen M. H., Mäkelä T. H., Wähälä K. T., Adlercreutz T. Soybean phytoestrogen intake and cancer risk. J Nutr. 1995 Mar;125(3 Suppl):757S–770S. doi: 10.1093/jn/125.3_Suppl.757S. [DOI] [PubMed] [Google Scholar]
  4. Adlercreutz Herman. Phytoestrogens and breast cancer. J Steroid Biochem Mol Biol. 2002 Dec;83(1-5):113–118. doi: 10.1016/s0960-0760(02)00273-x. [DOI] [PubMed] [Google Scholar]
  5. Alavanja M. C., Akland G., Baird D., Blair A., Bond A., Dosemeci M., Kamel F., Lewis R., Lubin J., Lynch C. Cancer and noncancer risk to women in agriculture and pest control: the Agricultural Health Study. J Occup Med. 1994 Nov;36(11):1247–1250. doi: 10.1097/00043764-199411000-00013. [DOI] [PubMed] [Google Scholar]
  6. Alden C. L. Safety assessment for non-genotoxic rodent carcinogens: curves, low-dose extrapolations, and mechanisms in carcinogenesis. Hum Exp Toxicol. 2000 Oct;19(10):557–572. doi: 10.1191/096032700701546451. [DOI] [PubMed] [Google Scholar]
  7. Ambrosone C. B., Freudenheim J. L., Graham S., Marshall J. R., Vena J. E., Brasure J. R., Michalek A. M., Laughlin R., Nemoto T., Gillenwater K. A. Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. JAMA. 1996 Nov 13;276(18):1494–1501. [PubMed] [Google Scholar]
  8. An J., Tzagarakis-Foster C., Scharschmidt T. C., Lomri N., Leitman D. C. Estrogen receptor beta-selective transcriptional activity and recruitment of coregulators by phytoestrogens. J Biol Chem. 2001 Feb 21;276(21):17808–17814. doi: 10.1074/jbc.M100953200. [DOI] [PubMed] [Google Scholar]
  9. Appel K. E., Fürstenberger G., Hapke H. J., Hecker E., Hildebrandt A. G., Koransky W., Marks F., Neumann H. G., Ohnesorge F. K., Schulte-Hermann R. Chemical cancerogenesis: definitions of frequently used terms. J Cancer Res Clin Oncol. 1990;116(3):232–236. doi: 10.1007/BF01612896. [DOI] [PubMed] [Google Scholar]
  10. Aschengrau A., Coogan P. F., Quinn M., Cashins L. J. Occupational exposure to estrogenic chemicals and the occurrence of breast cancer: an exploratory analysis. Am J Ind Med. 1998 Jul;34(1):6–14. doi: 10.1002/(sici)1097-0274(199807)34:1<6::aid-ajim2>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  11. Austin D. F., Roe K. M. Increase in cancer of the corpus uteri in the San Francisco-Oakland standard metropolitan statistical area, 1960--75. J Natl Cancer Inst. 1979 Jan;62(1):13–16. [PubMed] [Google Scholar]
  12. Band P. R., Le N. D., Fang R., Deschamps M., Gallagher R. P., Yang P. Identification of occupational cancer risks in British Columbia. A population-based case-control study of 995 incident breast cancer cases by menopausal status, controlling for confounding factors. J Occup Environ Med. 2000 Mar;42(3):284–310. doi: 10.1097/00043764-200003000-00010. [DOI] [PubMed] [Google Scholar]
  13. Band Pierre R., Le Nhu D., Fang Raymond, Deschamps Michèle. Carcinogenic and endocrine disrupting effects of cigarette smoke and risk of breast cancer. Lancet. 2002 Oct 5;360(9339):1044–1049. doi: 10.1016/S0140-6736(02)11140-8. [DOI] [PubMed] [Google Scholar]
  14. Barcellos-Hoff M. H. It takes a tissue to make a tumor: epigenetics, cancer and the microenvironment. J Mammary Gland Biol Neoplasia. 2001 Apr;6(2):213–221. doi: 10.1023/a:1011317009329. [DOI] [PubMed] [Google Scholar]
  15. Barcellos-Hoff M. H., Ravani S. A. Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. Cancer Res. 2000 Mar 1;60(5):1254–1260. [PubMed] [Google Scholar]
  16. Barrett J. C. Mechanisms of multistep carcinogenesis and carcinogen risk assessment. Environ Health Perspect. 1993 Apr;100:9–20. doi: 10.1289/ehp.931009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Bartsch H., Nair U., Risch A., Rojas M., Wikman H., Alexandrov K. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev. 2000 Jan;9(1):3–28. [PubMed] [Google Scholar]
  18. Basham V. M., Pharoah P. D., Healey C. S., Luben R. N., Day N. E., Easton D. F., Ponder B. A., Dunning A. M. Polymorphisms in CYP1A1 and smoking: no association with breast cancer risk. Carcinogenesis. 2001 Nov;22(11):1797–1800. doi: 10.1093/carcin/22.11.1797. [DOI] [PubMed] [Google Scholar]
  19. Bennett L. Michelle, Davis Barbara J. Identification of mammary carcinogens in rodent bioassays. Environ Mol Mutagen. 2002;39(2-3):150–157. doi: 10.1002/em.10068. [DOI] [PubMed] [Google Scholar]
  20. Bernstein Leslie, Allen Mark, Anton-Culver Hoda, Deapen Dennis, Horn-Ross Pamela L., Peel David, Pinder Richard, Reynolds Peggy, Sullivan-Halley Jane, West Dee. High breast cancer incidence rates among California teachers: results from the California Teachers Study (United States). Cancer Causes Control. 2002 Sep;13(7):625–635. doi: 10.1023/a:1019552126105. [DOI] [PubMed] [Google Scholar]
  21. Bernstein Leslie. Epidemiology of endocrine-related risk factors for breast cancer. J Mammary Gland Biol Neoplasia. 2002 Jan;7(1):3–15. doi: 10.1023/a:1015714305420. [DOI] [PubMed] [Google Scholar]
  22. Beyea J. Geographic exposure modeling: a valuable extension of geographic information systems for use in environmental epidemiology. Environ Health Perspect. 1999 Feb;107 (Suppl 1):181–190. doi: 10.1289/ehp.99107s1181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Birnbaum Linda S., Fenton Suzanne E. Cancer and developmental exposure to endocrine disruptors. Environ Health Perspect. 2003 Apr;111(4):389–394. doi: 10.1289/ehp.5686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Brisken Cathrin. Hormonal control of alveolar development and its implications for breast carcinogenesis. J Mammary Gland Biol Neoplasia. 2002 Jan;7(1):39–48. doi: 10.1023/a:1015718406329. [DOI] [PubMed] [Google Scholar]
  25. Brody J. G., Rudel R., Maxwell N. I., Swedis S. R. Mapping out a search for environmental causes of breast cancer. Public Health Rep. 1996 Nov-Dec;111(6):494–507. [PMC free article] [PubMed] [Google Scholar]
  26. Brody Julia Green, Vorhees Donna J., Melly Steven J., Swedis Susan R., Drivas Peter J., Rudel Ruthann A. Using GIS and historical records to reconstruct residential exposure to large-scale pesticide application. J Expo Anal Environ Epidemiol. 2002 Jan-Feb;12(1):64–80. doi: 10.1038/sj.jea.7500205. [DOI] [PubMed] [Google Scholar]
  27. Brown N. M., Manzolillo P. A., Zhang J. X., Wang J., Lamartiniere C. A. Prenatal TCDD and predisposition to mammary cancer in the rat. Carcinogenesis. 1998 Sep;19(9):1623–1629. doi: 10.1093/carcin/19.9.1623. [DOI] [PubMed] [Google Scholar]
  28. Caldwell J. C., Woodruff T. J., Morello-Frosch R., Axelrad D. A. Application of health information to hazardous air pollutants modeled in EPA's Cumulative Exposure Project. Toxicol Ind Health. 1998 May-Jun;14(3):429–454. doi: 10.1177/074823379801400304. [DOI] [PubMed] [Google Scholar]
  29. Calle E. E., Murphy T. K., Rodriguez C., Thun M. J., Heath C. W., Jr Occupation and breast cancer mortality in a prospective cohort of US women. Am J Epidemiol. 1998 Jul 15;148(2):191–197. doi: 10.1093/oxfordjournals.aje.a009623. [DOI] [PubMed] [Google Scholar]
  30. Cantor K. P., Stewart P. A., Brinton L. A., Dosemeci M. Occupational exposures and female breast cancer mortality in the United States. J Occup Environ Med. 1995 Mar;37(3):336–348. doi: 10.1097/00043764-199503000-00011. [DOI] [PubMed] [Google Scholar]
  31. Chang-Claude Jenny, Kropp Silke, Jäger Birgit, Bartsch Helmut, Risch Angela. Differential effect of NAT2 on the association between active and passive smoke exposure and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2002 Aug;11(8):698–704. [PubMed] [Google Scholar]
  32. Claus E. B., Schildkraut J. M., Thompson W. D., Risch N. J. The genetic attributable risk of breast and ovarian cancer. Cancer. 1996 Jun 1;77(11):2318–2324. doi: 10.1002/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO;2-Z. [DOI] [PubMed] [Google Scholar]
  33. Clegg Limin X., Feuer Eric J., Midthune Douglas N., Fay Michael P., Hankey Benjamin F. Impact of reporting delay and reporting error on cancer incidence rates and trends. J Natl Cancer Inst. 2002 Oct 16;94(20):1537–1545. doi: 10.1093/jnci/94.20.1537. [DOI] [PubMed] [Google Scholar]
  34. Colton T., Greenberg E. R., Noller K., Resseguie L., Van Bennekom C., Heeren T., Zhang Y. Breast cancer in mothers prescribed diethylstilbestrol in pregnancy. Further follow-up. JAMA. 1993 Apr 28;269(16):2096–2100. [PubMed] [Google Scholar]
  35. Davis D. L., Bradlow H. L., Wolff M., Woodruff T., Hoel D. G., Anton-Culver H. Medical hypothesis: xenoestrogens as preventable causes of breast cancer. Environ Health Perspect. 1993 Oct;101(5):372–377. doi: 10.1289/ehp.93101372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Deapen Dennis, Liu Lihua, Perkins Carin, Bernstein Leslie, Ross Ronald K. Rapidly rising breast cancer incidence rates among Asian-American women. Int J Cancer. 2002 Jun 10;99(5):747–750. doi: 10.1002/ijc.10415. [DOI] [PubMed] [Google Scholar]
  37. Desaulniers D., Leingartner K., Russo J., Perkins G., Chittim B. G., Archer M. C., Wade M., Yang J. Modulatory effects of neonatal exposure to TCDD, or a mixture of PCBs, p,p'-DDT, and p-p'-DDE, on methylnitrosourea-induced mammary tumor development in the rat. Environ Health Perspect. 2001 Jul;109(7):739–747. doi: 10.1289/ehp.01109739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Duell E. J., Millikan R. C., Savitz D. A., Newman B., Smith J. C., Schell M. J., Sandler D. P. A population-based case-control study of farming and breast cancer in North Carolina. Epidemiology. 2000 Sep;11(5):523–531. doi: 10.1097/00001648-200009000-00007. [DOI] [PubMed] [Google Scholar]
  39. Dunnick J. K., Elwell M. R., Huff J., Barrett J. C. Chemically induced mammary gland cancer in the National Toxicology Program's carcinogenesis bioassay. Carcinogenesis. 1995 Feb;16(2):173–179. doi: 10.1093/carcin/16.2.173. [DOI] [PubMed] [Google Scholar]
  40. Dunning A. M., Healey C. S., Pharoah P. D., Teare M. D., Ponder B. A., Easton D. F. A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1999 Oct;8(10):843–854. [PubMed] [Google Scholar]
  41. Emmen J. M., Korach K. S. Developing animal models for analyzing SERM activity. Ann N Y Acad Sci. 2001 Dec;949:36–43. doi: 10.1111/j.1749-6632.2001.tb04000.x. [DOI] [PubMed] [Google Scholar]
  42. Feigelson Heather Spencer, Jonas Carolyn R., Robertson Andreas S., McCullough Marjorie L., Thun Michael J., Calle Eugenia E. Alcohol, folate, methionine, and risk of incident breast cancer in the American Cancer Society Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev. 2003 Feb;12(2):161–164. [PubMed] [Google Scholar]
  43. Fenton Suzanne E., Hamm Jonathan T., Birnbaum Linda S., Youngblood Geri L. Persistent abnormalities in the rat mammary gland following gestational and lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol Sci. 2002 May;67(1):63–74. doi: 10.1093/toxsci/67.1.63. [DOI] [PubMed] [Google Scholar]
  44. Firozi Pervez F., Bondy Melissa L., Sahin Aysegul A., Chang Ping, Lukmanji Farzana, Singletary Eva S., Hassan Manal M., Li Donghui. Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer. Carcinogenesis. 2002 Feb;23(2):301–306. doi: 10.1093/carcin/23.2.301. [DOI] [PubMed] [Google Scholar]
  45. Ford Dianne. Mechanistic explanations for the chemopreventive action of soyabean isoflavones: reducing the possibilities. Br J Nutr. 2002 Nov;88(5):439–441. doi: 10.1079/BJN2002711. [DOI] [PubMed] [Google Scholar]
  46. Fotsis T., Pepper M., Adlercreutz H., Fleischmann G., Hase T., Montesano R., Schweigerer L. Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2690–2694. doi: 10.1073/pnas.90.7.2690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Friedberg T. Cytochrome P450 polymorphisms as risk factors for steroid hormone-related cancers. Am J Pharmacogenomics. 2001;1(2):83–91. doi: 10.2165/00129785-200101020-00001. [DOI] [PubMed] [Google Scholar]
  48. Gail M. H., Brinton L. A., Byar D. P., Corle D. K., Green S. B., Schairer C., Mulvihill J. J. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989 Dec 20;81(24):1879–1886. doi: 10.1093/jnci/81.24.1879. [DOI] [PubMed] [Google Scholar]
  49. Gammon Marilie D., Santella Regina M., Neugut Alfred I., Eng Sybil M., Teitelbaum Susan L., Paykin Andrea, Levin Bruce, Terry Mary Beth, Young Tie Lan, Wang Lian Wen. Environmental toxins and breast cancer on Long Island. I. Polycyclic aromatic hydrocarbon DNA adducts. Cancer Epidemiol Biomarkers Prev. 2002 Aug;11(8):677–685. [PubMed] [Google Scholar]
  50. Gammon Marilie D., Wolff Mary S., Neugut Alfred I., Eng Sybil M., Teitelbaum Susan L., Britton Julie A., Terry Mary Beth, Levin Bruce, Stellman Steven D., Kabat Geoffrey C. Environmental toxins and breast cancer on Long Island. II. Organochlorine compound levels in blood. Cancer Epidemiol Biomarkers Prev. 2002 Aug;11(8):686–697. [PubMed] [Google Scholar]
  51. Gandini S., Merzenich H., Robertson C., Boyle P. Meta-analysis of studies on breast cancer risk and diet: the role of fruit and vegetable consumption and the intake of associated micronutrients. Eur J Cancer. 2000 Mar;36(5):636–646. doi: 10.1016/s0959-8049(00)00022-8. [DOI] [PubMed] [Google Scholar]
  52. Ginsburg E. S., Walsh B. W., Shea B. F., Gao X., Gleason R. E., Barbieri R. L. The effects of ethanol on the clearance of estradiol in postmenopausal women. Fertil Steril. 1995 Jun;63(6):1227–1230. [PubMed] [Google Scholar]
  53. Goldberg M. S., Labrèche F. Occupational risk factors for female breast cancer: a review. Occup Environ Med. 1996 Mar;53(3):145–156. doi: 10.1136/oem.53.3.145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Gould J. C., Leonard L. S., Maness S. C., Wagner B. L., Conner K., Zacharewski T., Safe S., McDonnell D. P., Gaido K. W. Bisphenol A interacts with the estrogen receptor alpha in a distinct manner from estradiol. Mol Cell Endocrinol. 1998 Jul 25;142(1-2):203–214. doi: 10.1016/s0303-7207(98)00084-7. [DOI] [PubMed] [Google Scholar]
  55. Hamajima N., Hirose K., Tajima K., Rohan T., Calle E. E., Heath C. W., Jr, Coates R. J., Liff J. M., Talamini R., Chantarakul N. Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer. 2002 Nov 18;87(11):1234–1245. doi: 10.1038/sj.bjc.6600596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Hansen J. Breast cancer risk among relatively young women employed in solvent-using industries. Am J Ind Med. 1999 Jul;36(1):43–47. doi: 10.1002/(sici)1097-0274(199907)36:1<43::aid-ajim6>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  57. Harris C. A., Henttu P., Parker M. G., Sumpter J. P. The estrogenic activity of phthalate esters in vitro. Environ Health Perspect. 1997 Aug;105(8):802–811. doi: 10.1289/ehp.97105802. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Henderson B. E., Feigelson H. S. Hormonal carcinogenesis. Carcinogenesis. 2000 Mar;21(3):427–433. doi: 10.1093/carcin/21.3.427. [DOI] [PubMed] [Google Scholar]
  59. Hilakivi-Clarke L., Cho E., deAssis S., Olivo S., Ealley E., Bouker K. B., Welch J. N., Khan G., Clarke R., Cabanes A. Maternal and prepubertal diet, mammary development and breast cancer risk. J Nutr. 2001 Jan;131(1):154S–157S. doi: 10.1093/jn/131.1.154S. [DOI] [PubMed] [Google Scholar]
  60. Holmes M. D., Hunter D. J., Colditz G. A., Stampfer M. J., Hankinson S. E., Speizer F. E., Rosner B., Willett W. C. Association of dietary intake of fat and fatty acids with risk of breast cancer. JAMA. 1999 Mar 10;281(10):914–920. doi: 10.1001/jama.281.10.914. [DOI] [PubMed] [Google Scholar]
  61. Hunter D. J., Hankinson S. E., Hough H., Gertig D. M., Garcia-Closas M., Spiegelman D., Manson J. E., Colditz G. A., Willett W. C., Speizer F. E. A prospective study of NAT2 acetylation genotype, cigarette smoking, and risk of breast cancer. Carcinogenesis. 1997 Nov;18(11):2127–2132. doi: 10.1093/carcin/18.11.2127. [DOI] [PubMed] [Google Scholar]
  62. Hunter D. J., Willett W. C. Nutrition and breast cancer. Cancer Causes Control. 1996 Jan;7(1):56–68. doi: 10.1007/BF00115638. [DOI] [PubMed] [Google Scholar]
  63. Høyer A. P., Grandjean P., Jørgensen T., Brock J. W., Hartvig H. B. Organochlorine exposure and risk of breast cancer. Lancet. 1998 Dec 5;352(9143):1816–1820. doi: 10.1016/S0140-6736(98)04504-8. [DOI] [PubMed] [Google Scholar]
  64. Høyer A. P., Jørgensen T., Brock J. W., Grandjean P. Organochlorine exposure and breast cancer survival. J Clin Epidemiol. 2000 Mar 1;53(3):323–330. doi: 10.1016/s0895-4356(99)00165-1. [DOI] [PubMed] [Google Scholar]
  65. Høyer A. P., Jørgensen T., Grandjean P., Hartvig H. B. Repeated measurements of organochlorine exposure and breast cancer risk (Denmark). Cancer Causes Control. 2000 Feb;11(2):177–184. doi: 10.1023/a:1008926219539. [DOI] [PubMed] [Google Scholar]
  66. Høyer A. P., Jørgensen T., Rank F., Grandjean P. Organochlorine exposures influence on breast cancer risk and survival according to estrogen receptor status: a Danish cohort-nested case-control study. BMC Cancer. 2001 Jul 30;1:8–8. doi: 10.1186/1471-2407-1-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Høyer Annette Pernille, Gerdes Anne-Marie, Jørgensen Torben, Rank Fritz, Hartvig Helle Bøggild. Organochlorines, p53 mutations in relation to breast cancer risk and survival. A Danish cohort-nested case-controls study. Breast Cancer Res Treat. 2002 Jan;71(1):59–65. doi: 10.1023/a:1013340327099. [DOI] [PubMed] [Google Scholar]
  68. Jobling S., Reynolds T., White R., Parker M. G., Sumpter J. P. A variety of environmentally persistent chemicals, including some phthalate plasticizers, are weakly estrogenic. Environ Health Perspect. 1995 Jun;103(6):582–587. doi: 10.1289/ehp.95103582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Klaunig J. E., Kamendulis L. M., Xu Y. Epigenetic mechanisms of chemical carcinogenesis. Hum Exp Toxicol. 2000 Oct;19(10):543–555. doi: 10.1191/096032700701546442. [DOI] [PubMed] [Google Scholar]
  70. Kliewer E. V., Smith K. R. Breast cancer mortality among immigrants in Australia and Canada. J Natl Cancer Inst. 1995 Aug 2;87(15):1154–1161. doi: 10.1093/jnci/87.15.1154. [DOI] [PubMed] [Google Scholar]
  71. Korach K. S., McLachlan J. A. Techniques for detection of estrogenicity. Environ Health Perspect. 1995 Oct;103 (Suppl 7):5–8. doi: 10.1289/ehp.95103s75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Kreiger N., Sloan M., Cotterchio M., Kirsh V. The risk of breast cancer following reproductive surgery. Eur J Cancer. 1999 Jan;35(1):97–101. doi: 10.1016/s0959-8049(98)00343-8. [DOI] [PubMed] [Google Scholar]
  73. Kropp Silke, Chang-Claude Jenny. Active and passive smoking and risk of breast cancer by age 50 years among German women. Am J Epidemiol. 2002 Oct 1;156(7):616–626. doi: 10.1093/aje/kwf093. [DOI] [PubMed] [Google Scholar]
  74. Laden F., Spiegelman D., Neas L. M., Colditz G. A., Hankinson S. E., Manson J. E., Byrne C., Rosner B. A., Speizer F. E., Hunter D. J. Geographic variation in breast cancer incidence rates in a cohort of U.S. women. J Natl Cancer Inst. 1997 Sep 17;89(18):1373–1378. doi: 10.1093/jnci/89.18.1373. [DOI] [PubMed] [Google Scholar]
  75. Laden Francine, Ishibe Naoko, Hankinson Susan E., Wolff Mary S., Gertig Dorota M., Hunter David J., Kelsey Karl T. Polychlorinated biphenyls, cytochrome P450 1A1, and breast cancer risk in the Nurses' Health Study. Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1560–1565. [PubMed] [Google Scholar]
  76. Lamartiniere C. A., Moore J., Holland M., Barnes S. Neonatal genistein chemoprevents mammary cancer. Proc Soc Exp Biol Med. 1995 Jan;208(1):120–123. doi: 10.3181/00379727-208-43843. [DOI] [PubMed] [Google Scholar]
  77. Land C. E. Studies of cancer and radiation dose among atomic bomb survivors. The example of breast cancer. JAMA. 1995 Aug 2;274(5):402–407. [PubMed] [Google Scholar]
  78. Liehr J. G., Roy D., Ari-Ulubelen A., Bui Q. D., Weisz J., Strobel H. W. Effect of chronic estrogen treatment of Syrian hamsters on microsomal enzymes mediating formation of catecholestrogens and their redox cycling: implications for carcinogenesis. J Steroid Biochem. 1990 Apr;35(5):555–560. doi: 10.1016/0022-4731(90)90198-2. [DOI] [PubMed] [Google Scholar]
  79. Lynberg M., Nuckols J. R., Langlois P., Ashley D., Singer P., Mendola P., Wilkes C., Krapfl H., Miles E., Speight V. Assessing exposure to disinfection by-products in women of reproductive age living in Corpus Christi, Texas, and Cobb county, Georgia: descriptive results and methods. Environ Health Perspect. 2001 Jun;109(6):597–604. doi: 10.1289/ehp.01109597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Mack T. M., Hamilton A. S., Press M. F., Diep A., Rappaport E. B. Heritable breast cancer in twins. Br J Cancer. 2002 Jul 29;87(3):294–300. doi: 10.1038/sj.bjc.6600429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Madigan M. P., Ziegler R. G., Benichou J., Byrne C., Hoover R. N. Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst. 1995 Nov 15;87(22):1681–1685. doi: 10.1093/jnci/87.22.1681. [DOI] [PubMed] [Google Scholar]
  82. Markaverich B. M., Webb B., Densmore C. L., Gregory R. R. Effects of coumestrol on estrogen receptor function and uterine growth in ovariectomized rats. Environ Health Perspect. 1995 Jun;103(6):574–581. doi: 10.1289/ehp.95103574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Martin A. M., Weber B. L. Genetic and hormonal risk factors in breast cancer. J Natl Cancer Inst. 2000 Jul 19;92(14):1126–1135. doi: 10.1093/jnci/92.14.1126. [DOI] [PubMed] [Google Scholar]
  84. Michels Karin B. The contribution of the environment (especially diet) to breast cancer risk. Breast Cancer Res. 2002 Feb 12;4(2):58–61. doi: 10.1186/bcr423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Morabia A., Bernstein M. S., Bouchardy I., Kurtz J., Morris M. A. Breast cancer and active and passive smoking: the role of the N-acetyltransferase 2 genotype. Am J Epidemiol. 2000 Aug 1;152(3):226–232. doi: 10.1093/aje/152.3.226. [DOI] [PubMed] [Google Scholar]
  86. Moysich K. B., Shields P. G., Freudenheim J. L., Schisterman E. F., Vena J. E., Kostyniak P., Greizerstein H., Marshall J. R., Graham S., Ambrosone C. B. Polychlorinated biphenyls, cytochrome P4501A1 polymorphism, and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1999 Jan;8(1):41–44. [PubMed] [Google Scholar]
  87. Mueller Stefan O., Clark James A., Myers Page H., Korach Kenneth S. Mammary gland development in adult mice requires epithelial and stromal estrogen receptor alpha. Endocrinology. 2002 Jun;143(6):2357–2365. doi: 10.1210/endo.143.6.8836. [DOI] [PubMed] [Google Scholar]
  88. Neumann D. A., Crisp T. M., Olin S. S. Mammary gland neoplasia. Environ Health Perspect. 1996 Sep;104(9):912–914. doi: 10.1289/ehp.96104912. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Norman S. A., Berlin J. A., Soper K. A., Middendorf B. F., Stolley P. D. Cancer incidence in a group of workers potentially exposed to ethylene oxide. Int J Epidemiol. 1995 Apr;24(2):276–284. doi: 10.1093/ije/24.2.276. [DOI] [PubMed] [Google Scholar]
  90. O'Connor J. C., Cook J. C., Craven S. C., Van Pelt C. S., Obourn J. D. An in vivo battery for identifying endocrine modulators that are estrogenic or dopamine regulators. Fundam Appl Toxicol. 1996 Oct;33(2):182–195. [PubMed] [Google Scholar]
  91. Parazzini F., Braga C., La Vecchia C., Negri E., Acerboni S., Franceschi S. Hysterectomy, oophorectomy in premenopause, and risk of breast cancer. Obstet Gynecol. 1997 Sep;90(3):453–456. doi: 10.1016/s0029-7844(97)00295-0. [DOI] [PubMed] [Google Scholar]
  92. Parkin D. M., Bray F. I., Devesa S. S. Cancer burden in the year 2000. The global picture. Eur J Cancer. 2001 Oct;37 (Suppl 8):S4–66. doi: 10.1016/s0959-8049(01)00267-2. [DOI] [PubMed] [Google Scholar]
  93. Pennie W. D., Aldridge T. C., Brooks A. N. Differential activation by xenoestrogens of ER alpha and ER beta when linked to different response elements. J Endocrinol. 1998 Sep;158(3):R11–R14. doi: 10.1677/joe.0.158r011. [DOI] [PubMed] [Google Scholar]
  94. Perera F. P. Molecular epidemiology: on the path to prevention? J Natl Cancer Inst. 2000 Apr 19;92(8):602–612. doi: 10.1093/jnci/92.8.602. [DOI] [PubMed] [Google Scholar]
  95. Petralia S. A., Chow W. H., McLaughlin J., Jin F., Gao Y. T., Dosemeci M. Occupational risk factors for breast cancer among women in Shanghai. Am J Ind Med. 1998 Nov;34(5):477–483. doi: 10.1002/(sici)1097-0274(199811)34:5<477::aid-ajim8>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  96. Petralia S. A., Vena J. E., Freudenheim J. L., Dosemeci M., Michalek A., Goldberg M. S., Brasure J., Graham S. Risk of premenopausal breast cancer in association with occupational exposure to polycyclic aromatic hydrocarbons and benzene. Scand J Work Environ Health. 1999 Jun;25(3):215–221. doi: 10.5271/sjweh.426. [DOI] [PubMed] [Google Scholar]
  97. Pharoah Paul D. P., Antoniou Antonis, Bobrow Martin, Zimmern Ron L., Easton Douglas F., Ponder Bruce A. J. Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet. 2002 Mar 4;31(1):33–36. doi: 10.1038/ng853. [DOI] [PubMed] [Google Scholar]
  98. Pintér A., Török G., Börzsönyi M., Surján A., Csík M., Kelecsényi Z., Kocsis Z. Long-term carcinogenicity bioassay of the herbicide atrazine in F344 rats. Neoplasma. 1990;37(5):533–544. [PubMed] [Google Scholar]
  99. Pitot H. C., Dragan Y. P. Facts and theories concerning the mechanisms of carcinogenesis. FASEB J. 1991 Jun;5(9):2280–2286. [PubMed] [Google Scholar]
  100. Pitot H. C., Hikita H., Dragan Y., Sargent L., Haas M. Review article: the stages of gastrointestinal carcinogenesis--application of rodent models to human disease. Aliment Pharmacol Ther. 2000 Apr;14 (Suppl 1):153–160. doi: 10.1046/j.1365-2036.2000.014s1153.x. [DOI] [PubMed] [Google Scholar]
  101. Po Lai See, Wang Thomas T., Chen Zhen-Yu, Leung Lai K. Genistein-induced apoptosis in MCF-7 cells involves changes in Bak and Bcl-x without evidence of anti-oestrogenic effects. Br J Nutr. 2002 Nov;88(5):463–469. doi: 10.1079/BJN2002693. [DOI] [PubMed] [Google Scholar]
  102. Pollán M., Gustavsson P. High-risk occupations for breast cancer in the Swedish female working population. Am J Public Health. 1999 Jun;89(6):875–881. doi: 10.2105/ajph.89.6.875. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Prehn A. W., West D. W. Evaluating local differences in breast cancer incidence rates: a census-based methodology (United States). Cancer Causes Control. 1998 Oct;9(5):511–517. doi: 10.1023/a:1008809819218. [DOI] [PubMed] [Google Scholar]
  104. Robbins A. S., Brescianini S., Kelsey J. L. Regional differences in known risk factors and the higher incidence of breast cancer in San Francisco. J Natl Cancer Inst. 1997 Jul 2;89(13):960–965. doi: 10.1093/jnci/89.13.960. [DOI] [PubMed] [Google Scholar]
  105. Rossouw Jacques E., Anderson Garnet L., Prentice Ross L., LaCroix Andrea Z., Kooperberg Charles, Stefanick Marcia L., Jackson Rebecca D., Beresford Shirley A. A., Howard Barbara V., Johnson Karen C. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002 Jul 17;288(3):321–333. doi: 10.1001/jama.288.3.321. [DOI] [PubMed] [Google Scholar]
  106. Routledge E. J., Parker J., Odum J., Ashby J., Sumpter J. P. Some alkyl hydroxy benzoate preservatives (parabens) are estrogenic. Toxicol Appl Pharmacol. 1998 Nov;153(1):12–19. doi: 10.1006/taap.1998.8544. [DOI] [PubMed] [Google Scholar]
  107. Rudel R. A., Brody J. G., Spengler J. D., Vallarino J., Geno P. W., Sun G., Yau A. Identification of selected hormonally active agents and animal mammary carcinogens in commercial and residential air and dust samples. J Air Waste Manag Assoc. 2001 Apr;51(4):499–513. doi: 10.1080/10473289.2001.10464292. [DOI] [PubMed] [Google Scholar]
  108. Rudel R. Predicting health effects of exposures to compounds with estrogenic activity: methodological issues. Environ Health Perspect. 1997 Apr;105 (Suppl 3):655–663. doi: 10.1289/ehp.97105s3655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Russo I. H., Russo J. Mammary gland neoplasia in long-term rodent studies. Environ Health Perspect. 1996 Sep;104(9):938–967. doi: 10.1289/ehp.96104938. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Safe S. H. Environmental and dietary estrogens and human health: is there a problem? Environ Health Perspect. 1995 Apr;103(4):346–351. doi: 10.1289/ehp.95103346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Scribner J. D., Mottet N. K. DDT acceleration of mammary gland tumors induced in the male Sprague-Dawley rat by 2-acetamidophenanthrene. Carcinogenesis. 1981;2(12):1235–1239. doi: 10.1093/carcin/2.12.1235. [DOI] [PubMed] [Google Scholar]
  112. Shelby M. D., Newbold R. R., Tully D. B., Chae K., Davis V. L. Assessing environmental chemicals for estrogenicity using a combination of in vitro and in vivo assays. Environ Health Perspect. 1996 Dec;104(12):1296–1300. doi: 10.1289/ehp.961041296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  113. Silva Elisabete, Rajapakse Nissanka, Kortenkamp Andreas. Something from "nothing"--eight weak estrogenic chemicals combined at concentrations below NOECs produce significant mixture effects. Environ Sci Technol. 2002 Apr 15;36(8):1751–1756. doi: 10.1021/es0101227. [DOI] [PubMed] [Google Scholar]
  114. Singletary K. W., Gapstur S. M. Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms. JAMA. 2001 Nov 7;286(17):2143–2151. doi: 10.1001/jama.286.17.2143. [DOI] [PubMed] [Google Scholar]
  115. Sivaraman Lakshmi, Medina Daniel. Hormone-induced protection against breast cancer. J Mammary Gland Biol Neoplasia. 2002 Jan;7(1):77–92. doi: 10.1023/a:1015774524076. [DOI] [PubMed] [Google Scholar]
  116. Smith-Warner S. A., Spiegelman D., Yaun S. S., Adami H. O., Beeson W. L., van den Brandt P. A., Folsom A. R., Fraser G. E., Freudenheim J. L., Goldbohm R. A. Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studies. JAMA. 2001 Feb 14;285(6):769–776. doi: 10.1001/jama.285.6.769. [DOI] [PubMed] [Google Scholar]
  117. Smith E. R., Quinn M. M. Uterotropic action in rats of amsonic acid and three of its synthetic precursors. J Toxicol Environ Health. 1992 May;36(1):13–25. doi: 10.1080/15287399209531620. [DOI] [PubMed] [Google Scholar]
  118. Snedeker S. M. Pesticides and breast cancer risk: a review of DDT, DDE, and dieldrin. Environ Health Perspect. 2001 Mar;109 (Suppl 1):35–47. doi: 10.1289/ehp.01109s135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Soto A. M., Sonnenschein C., Chung K. L., Fernandez M. F., Olea N., Serrano F. O. The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ Health Perspect. 1995 Oct;103 (Suppl 7):113–122. doi: 10.1289/ehp.95103s7113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Stellman Jeanne Mager, Stellman Steven D., Weber Tracy, Tomasallo Carrie, Stellman Andrew B., Christian Richard., Jr A geographic information system for characterizing exposure to Agent Orange and other herbicides in Vietnam. Environ Health Perspect. 2003 Mar;111(3):321–328. doi: 10.1289/ehp.5755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  121. Sturgeon S. R., Schairer C., Gail M., McAdams M., Brinton L. A., Hoover R. N. Geographic variation in mortality from breast cancer among white women in the United States. J Natl Cancer Inst. 1995 Dec 20;87(24):1846–1853. doi: 10.1093/jnci/87.24.1846. [DOI] [PubMed] [Google Scholar]
  122. Swanson Steven M., Unterman Terry G. The growth hormone-deficient Spontaneous Dwarf rat is resistant to chemically induced mammary carcinogenesis. Carcinogenesis. 2002 Jun;23(6):977–982. doi: 10.1093/carcin/23.6.977. [DOI] [PubMed] [Google Scholar]
  123. Telang N. T., Suto A., Wong G. Y., Osborne M. P., Bradlow H. L. Induction by estrogen metabolite 16 alpha-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells. J Natl Cancer Inst. 1992 Apr 15;84(8):634–638. doi: 10.1093/jnci/84.8.634. [DOI] [PubMed] [Google Scholar]
  124. Titus-Ernstoff L., Hatch E. E., Hoover R. N., Palmer J., Greenberg E. R., Ricker W., Kaufman R., Noller K., Herbst A. L., Colton T. Long-term cancer risk in women given diethylstilbestrol (DES) during pregnancy. Br J Cancer. 2001 Jan 5;84(1):126–133. doi: 10.1054/bjoc.2000.1521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  125. Tokunaga M., Land C. E., Yamamoto T., Asano M., Tokuoka S., Ezaki H., Nishimori I. Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1980. Radiat Res. 1987 Nov;112(2):243–272. [PubMed] [Google Scholar]
  126. Tompa A., Major J., Jakab M. G. Is breast cancer cluster influenced by environmental and occupational factors among hospital nurses in Hungary? Pathol Oncol Res. 1999;5(2):117–121. doi: 10.1053/paor.1999.0182. [DOI] [PubMed] [Google Scholar]
  127. Toniolo P., Bruning P. F., Akhmedkhanov A., Bonfrer J. M., Koenig K. L., Lukanova A., Shore R. E., Zeleniuch-Jacquotte A. Serum insulin-like growth factor-I and breast cancer. Int J Cancer. 2000 Dec 1;88(5):828–832. doi: 10.1002/1097-0215(20001201)88:5<828::aid-ijc22>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  128. Tsutsui T., Barrett J. C. Neoplastic transformation of cultured mammalian cells by estrogens and estrogenlike chemicals. Environ Health Perspect. 1997 Apr;105 (Suppl 3):619–624. doi: 10.1289/ehp.97105s3619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  129. Ursin G., Bernstein L., Pike M. C. Breast cancer. Cancer Surv. 1994;19-20:241–264. [PubMed] [Google Scholar]
  130. Wang D. Y., Allen D. S., De Stavola B. L., Fentiman I. S., Brussen J., Bulbrook R. D., Thomas B. S., Hayward J. L., Reed M. J. Urinary androgens and breast cancer risk: results from a long-term prospective study based in Guernsey. Br J Cancer. 2000 May;82(9):1577–1584. doi: 10.1054/bjoc.1999.1180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  131. Ward M. H., Nuckols J. R., Weigel S. J., Maxwell S. K., Cantor K. P., Miller R. S. Identifying populations potentially exposed to agricultural pesticides using remote sensing and a Geographic Information System. Environ Health Perspect. 2000 Jan;108(1):5–12. doi: 10.1289/ehp.001085. [DOI] [PMC free article] [PubMed] [Google Scholar]
  132. Warner Marcella, Eskenazi Brenda, Mocarelli Paolo, Gerthoux Pier Mario, Samuels Steven, Needham Larry, Patterson Donald, Brambilla Paolo. Serum dioxin concentrations and breast cancer risk in the Seveso Women's Health Study. Environ Health Perspect. 2002 Jul;110(7):625–628. doi: 10.1289/ehp.02110625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. Willett W. C. Dietary fat and breast cancer. Toxicol Sci. 1999 Dec;52(2 Suppl):127–146. doi: 10.1093/toxsci/52.2.127. [DOI] [PubMed] [Google Scholar]
  134. Wolff M. S., Collman G. W., Barrett J. C., Huff J. Breast cancer and environmental risk factors: epidemiological and experimental findings. Annu Rev Pharmacol Toxicol. 1996;36:573–596. doi: 10.1146/annurev.pa.36.040196.003041. [DOI] [PubMed] [Google Scholar]
  135. Wu A. H., Ziegler R. G., Pike M. C., Nomura A. M., West D. W., Kolonel L. N., Horn-Ross P. L., Rosenthal J. F., Hoover R. N. Menstrual and reproductive factors and risk of breast cancer in Asian-Americans. Br J Cancer. 1996 Mar;73(5):680–686. doi: 10.1038/bjc.1996.118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  136. Wu Anna H., Wan Peggy, Hankin Jean, Tseng Chiu-Chen, Yu Mimi C., Pike Malcolm C. Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis. 2002 Sep;23(9):1491–1496. doi: 10.1093/carcin/23.9.1491. [DOI] [PubMed] [Google Scholar]
  137. Zhang Shumin M., Willett Walter C., Selhub Jacob, Hunter David J., Giovannucci Edward L., Holmes Michelle D., Colditz Graham A., Hankinson Susan E. Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer. J Natl Cancer Inst. 2003 Mar 5;95(5):373–380. doi: 10.1093/jnci/95.5.373. [DOI] [PubMed] [Google Scholar]
  138. Zheng Tongzhang, Holford Theodore R., Zahm Shelia H., Owens Patricia H., Boyle Peter, Zhang Yawei, Wise John Pierce, Sr, Stephenson Lisa Pleasants, Ali-Osman Francis. Cigarette smoking, glutathione-s-transferase M1 and t1 genetic polymorphisms, and breast cancer risk (United States). Cancer Causes Control. 2002 Sep;13(7):637–645. doi: 10.1023/a:1019500109267. [DOI] [PubMed] [Google Scholar]
  139. Zheng Wei, Wen Wan-Qing, Gustafson Deborah R., Gross Myron, Cerhan James R., Folsom Aaron R. GSTM1 and GSTT1 polymorphisms and postmenopausal breast cancer risk. Breast Cancer Res Treat. 2002 Jul;74(1):9–16. doi: 10.1023/a:1016005100958. [DOI] [PubMed] [Google Scholar]
  140. Ziegler R. G., Hoover R. N., Pike M. C., Hildesheim A., Nomura A. M., West D. W., Wu-Williams A. H., Kolonel L. N., Horn-Ross P. L., Rosenthal J. F. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst. 1993 Nov 17;85(22):1819–1827. doi: 10.1093/jnci/85.22.1819. [DOI] [PubMed] [Google Scholar]
  141. Zile M. H., Welsch C. W., Welsch M. A. Effect of wheat bran fiber on the development of mammary tumors in female intact and ovariectomized rats treated with 7,12-dimethylbenz(a)anthracene and in mice with spontaneously developing mammary tumors. Int J Cancer. 1998 Jan 30;75(3):439–443. doi: 10.1002/(sici)1097-0215(19980130)75:3<439::aid-ijc18>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES